These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 22788808

  • 21. Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma.
    Wright A, Wijeratne A, Hung T, Gao W, Whittaker S, Morris S, Scarisbrick J, Beynon T.
    J Pain Symptom Manage; 2013 Jan; 45(1):114-9. PubMed ID: 22917715
    [Abstract] [Full Text] [Related]

  • 22. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR, Bethaney JV.
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [Abstract] [Full Text] [Related]

  • 23. Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease.
    Malek M, Gleń J, Rębała K, Kowalczyk A, Sobjanek M, Nowicki R, Ruckemann-Dziurdzińska K, Sokołowska-Wojdyło M.
    Acta Derm Venereol; 2015 Mar; 95(3):283-8. PubMed ID: 25176053
    [Abstract] [Full Text] [Related]

  • 24. AGNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas.
    Qiu BS, Xu LZ, Kong JC, Chen HL, Tao LD.
    Chin Med J (Engl); 1992 Jan; 105(1):30-3. PubMed ID: 1576867
    [Abstract] [Full Text] [Related]

  • 25. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome.
    Talpur R, Bassett R, Duvic M.
    Br J Dermatol; 2008 Jul; 159(1):105-12. PubMed ID: 18489588
    [Abstract] [Full Text] [Related]

  • 26. Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series.
    Jahan-Tigh RR, Huen AO, Lee GL, Pozadzides JV, Liu P, Duvic M.
    Cancer; 2013 Feb 15; 119(4):825-31. PubMed ID: 22952039
    [Abstract] [Full Text] [Related]

  • 27. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S, Black RA, Nagao M, Sepassi M, Sharma G, Thornton S, Kim YH, Braverman J.
    J Med Internet Res; 2019 Jan 07; 21(1):e11302. PubMed ID: 30617041
    [Abstract] [Full Text] [Related]

  • 28. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES, Tang MB, Tan SH.
    Australas J Dermatol; 2006 Nov 07; 47(4):248-52. PubMed ID: 17034466
    [Abstract] [Full Text] [Related]

  • 29. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E, David M, Maron L, Aviram A, Kaganovsky E, Feinmesser M.
    J Am Acad Dermatol; 2006 Aug 07; 55(2):276-84. PubMed ID: 16844512
    [Abstract] [Full Text] [Related]

  • 30. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J, Schmid K, Trautinger F, Wallnöfer W, Muellauer L, Soleiman A, Knobler R, Haitel A, Pehamberger H, Raderer M.
    J Dermatol Sci; 2011 Dec 07; 64(3):185-90. PubMed ID: 21937200
    [Abstract] [Full Text] [Related]

  • 31. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A, Dhungel BM, Khan MF.
    J Cutan Pathol; 2006 Sep 07; 33 Suppl 2():12-5. PubMed ID: 16972946
    [Abstract] [Full Text] [Related]

  • 32. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
    Ai WZ, Keegan TH, Press DJ, Yang J, Pincus LB, Kim YH, Chang ET.
    JAMA Dermatol; 2014 Jul 07; 150(7):709-15. PubMed ID: 24718769
    [Abstract] [Full Text] [Related]

  • 33. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Duarte RF, Canals C, Onida F, Gabriel IH, Arranz R, Arcese W, Ferrant A, Kobbe G, Narni F, Deliliers GL, Olavarría E, Schmitz N, Sureda A.
    J Clin Oncol; 2010 Oct 10; 28(29):4492-9. PubMed ID: 20697072
    [Abstract] [Full Text] [Related]

  • 34. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Pehr K, Sasseville D, Litvinov IV.
    Cancer; 2017 Sep 15; 123(18):3550-3567. PubMed ID: 28493286
    [Abstract] [Full Text] [Related]

  • 35. Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas.
    de Masson A, Guitera P, Brice P, Moulonguet I, Mouly F, Bouaziz JD, Battistella M, Madelaine I, Roux J, Ram-Wolff C, Cayuela JM, Bachelez H, Bensussan A, Michel L, Bagot M.
    Br J Dermatol; 2014 Mar 15; 170(3):720-4. PubMed ID: 24438061
    [Abstract] [Full Text] [Related]

  • 36. Acitretin for the treatment of cutaneous T-cell lymphoma.
    Cheeley J, Sahn RE, DeLong LK, Parker SR.
    J Am Acad Dermatol; 2013 Feb 15; 68(2):247-54. PubMed ID: 22917895
    [Abstract] [Full Text] [Related]

  • 37. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 38. Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
    Anadolu RY, Birol A, Sanli H, Erdem C, Türsen U.
    Int J Dermatol; 2005 Jul 01; 44(7):559-65. PubMed ID: 15985024
    [Abstract] [Full Text] [Related]

  • 39. Epidemiology and prognostic factors for mycosis fungoides and Sézary syndrome in a multi-ethnic Asian cohort: a 12-year review.
    Lim HLJ, Tan EST, Tee SI, Ho ZY, Boey JJJ, Tan WP, Tang MBY, Shen L, Chan YH, Tan SH.
    J Eur Acad Dermatol Venereol; 2019 Aug 01; 33(8):1513-1521. PubMed ID: 30801779
    [Abstract] [Full Text] [Related]

  • 40. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH, Prinz BM, Guitart J.
    Arch Dermatol; 2005 Mar 01; 141(3):305-11. PubMed ID: 15781671
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.